Cardiac sarcoidosis is an uncommon and frequently overlooked condition characterized by the formation of inflammatory granulomas within the heart tissue. This intricately connected aspect of sarcoidosis, a systemic inflammatory disorder impacting multiple organs, presents unique challenges when it involves the heart. The origin of cardiac sarcoidosis remains elusive, with suspicions pointing toward an abnormal immune response. Symptoms manifest diversely, ranging from arrhythmias and conduction abnormalities to heart failure. Pinpointing cardiac sarcoidosis necessitates a multifaceted diagnostic approach, incorporating clinical assessment and advanced imaging techniques such as cardiac MRI or PET scans, occasionally augmented by cardiac biopsy. Timely identification is paramount, given the potential for significant morbidity and mortality if left untreated. Treatment strategies typically involve immunosuppressive medications aimed at quelling inflammation and managing symptoms. In light of its rarity, fostering increased awareness and fostering collaborative efforts among healthcare professionals are imperative for enhancing early detection and effective management of cardiac sarcoidosis.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt